Energy, basic resources, luxury the best performers; tech, food/beverage and healthcare the main laggards:
StreetAccount Summary - European pre-market trading update
Lonza Group Q3 qualitative update: FY outlook confirmed for CDMO, CHI businesses (CHF 560.00, 0.00)
White House says the latest pharmaceutical tariffs do not apply to countries with negotiated trade deals -- wires
European pharma and truck exports threatened by renewed Trump tariffs:
Trump says pharmaceutical products imported into US will be hit with 100% tariff starting 1-Oct - Truth Social post
Vaxcyte advances VAX-31 infant hase 2 dose-finding study with first participants receiving VAX-31 optimized dose ($31.56, 0.00)
StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Sector Summary - Healthcare Pre-Market
Powered by FactSet Research Systems Inc.